Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
Clinical trial NCT03630055 · TERMINATED
Trial details
- NCT number
- NCT03630055
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2025-06-26
- Enrollment
- 930
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.